Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Elevated plasma levels of clozapine after concomitant use of fluvoxamine.

Heeringa M, Beurskens R, Schouten W, Verduijn MM.

Pharm World Sci. 1999 Oct;21(5):243-4.

PMID:
10550852
[PubMed - indexed for MEDLINE]
2.

Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.

Brøsen K.

Clin Pharmacokinet. 1995;29 Suppl 1:20-5. Review.

PMID:
8846619
[PubMed - indexed for MEDLINE]
3.

Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.

Lu ML, Lane HY, Chen KP, Jann MW, Su MH, Chang WH.

J Clin Psychiatry. 2000 Aug;61(8):594-9.

PMID:
10982203
[PubMed - indexed for MEDLINE]
4.

[Serious drug interaction between clozapine-Leponex and fluvoxamine-Fevarin].

Olesen OV, Starup G, Linnet K.

Ugeskr Laeger. 1996 Nov 25;158(48):6931-2. Danish.

PMID:
8984760
[PubMed - indexed for MEDLINE]
5.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. Review.

PMID:
9435993
[PubMed - indexed for MEDLINE]
6.

Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.

Andrade C.

J Clin Psychiatry. 2012 Nov;73(11):e1362-4. doi: 10.4088/JCP.12f08200. No abstract available.

PMID:
23218164
[PubMed - indexed for MEDLINE]
7.

[Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].

Papetti F, Morel-Pingault V, Buisse V, Maziere L, Banayan M, Thauby S, Besnard T, Darcourt G, Pringuey D.

Encephale. 2007 Oct;33(5):811-8. French.

PMID:
18357853
[PubMed - indexed for MEDLINE]
8.

Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro.

Rasmussen BB, Nielsen TL, Brøsen K.

Pharmacol Toxicol. 1998 Dec;83(6):240-5.

PMID:
9868741
[PubMed - indexed for MEDLINE]
9.

Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment.

Chertkow Y, Weinreb O, Youdim MB, Silver H.

J Neural Transm. 2007;114(11):1443-54. Epub 2007 Jun 18. Erratum in: J Neural Transm. 2007;114(11):1455.

PMID:
17576515
[PubMed - indexed for MEDLINE]
10.

Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer.

Joos AA, König F, Frank UG, Kaschka WP, Mörike KE, Ewald R.

Pharmacopsychiatry. 1997 Nov;30(6):266-70.

PMID:
9442550
[PubMed - indexed for MEDLINE]
11.

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.

Ozdemir V, Kalow W, Okey AB, Lam MS, Albers LJ, Reist C, Fourie J, Posner P, Collins EJ, Roy R.

J Clin Psychopharmacol. 2001 Dec;21(6):603-7.

PMID:
11763009
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.

Wetzel H, Anghelescu I, Szegedi A, Wiesner J, Weigmann H, Härter S, Hiemke C.

J Clin Psychopharmacol. 1998 Feb;18(1):2-9.

PMID:
9472836
[PubMed - indexed for MEDLINE]
13.

Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism.

Olesen OV, Linnet K.

J Clin Psychopharmacol. 2000 Feb;20(1):35-42.

PMID:
10653206
[PubMed - indexed for MEDLINE]
14.

Fluvoxamine as an adjunctive agent in schizophrenia.

Silver H.

CNS Drug Rev. 2001 Fall;7(3):283-304. Review.

PMID:
11607044
[PubMed - indexed for MEDLINE]
15.

Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight.

Hinze-Selch D, Deuschle M, Weber B, Heuser I, Pollmächer T.

Psychopharmacology (Berl). 2000 Apr;149(2):163-9.

PMID:
10805611
[PubMed - indexed for MEDLINE]
16.

Fluvoxamine. A review of global drug-drug interaction data.

Wagner W, Vause EW.

Clin Pharmacokinet. 1995;29 Suppl 1:26-31; discussion 31-2. Review.

PMID:
8846620
[PubMed - indexed for MEDLINE]
17.

Fluvoxamine-clozapine interaction: time-dependent?

Lu ML, Lane HY, Chang WH.

J Clin Psychopharmacol. 2002 Aug;22(4):439-40. No abstract available.

PMID:
12172350
[PubMed - indexed for MEDLINE]
18.

Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).

Christensen M, Tybring G, Mihara K, Yasui-Furokori N, Carrillo JA, Ramos SI, Andersson K, Dahl ML, Bertilsson L.

Clin Pharmacol Ther. 2002 Mar;71(3):141-52.

PMID:
11907488
[PubMed - indexed for MEDLINE]
19.

[Pharmacokinetics and drug interactions of antidepressive agents].

Sawada Y, Ohtani H.

Nihon Rinsho. 2001 Aug;59(8):1539-45. Review. Japanese.

PMID:
11519155
[PubMed - indexed for MEDLINE]
20.

The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.

Daniel WA, Syrek M, Haduch A, Wójcikowski J.

J Pharm Pharmacol. 2001 Apr;53(4):449-61.

PMID:
11341361
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk